Seizure disorders: Update of medical and dental considerations

General Dentistry

Volumn 51, Issue 4, 2003, Pages 361-366

  Stoopler, Eric T ^a   Sollecito, Thomas P ^b   Greenberg, Martin S ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Oral Medicine Residency Program   (United States)

^c Department of Oral Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHYLLINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CENTRAL DEPRESSANT AGENT; CHLORHEXIDINE; CLONAZEPAM; DEXTROPROPOXYPHENE; DIAZEPAM; ERYTHROMYCIN; ETHOSUXIMIDE; FLUORIDE; FOLIC ACID; GABAPENTIN; HEMOSTATIC AGENT; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXCARBAZEPINE; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN;

ABSENCE; ACNE; ALOPECIA; ATAXIA; ATONIC SEIZURE; BLEEDING; BLOOD CLOTTING; BLOOD DYSCRASIA; CLINICAL FEATURE; CLINICAL TRIAL; CLONIC SEIZURE; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; DENTAL CARE; DENTIST; DENTISTRY; DEPRESSION; DIAGNOSTIC TEST; DIPLOPIA; DISEASE CLASSIFICATION; DIZZINESS; DROWSINESS; DRUG MECHANISM; ELECTROENCEPHALOGRAM; EMERGENCY TREATMENT; EPILEPSY; EPILEPTIC STATE; FATIGUE; FOCAL EPILEPSY; GINGIVA BLEEDING; GINGIVA HYPERTROPHY; GRAND MAL SEIZURE; HEADACHE; HUMAN; IMPOTENCE; INFECTION; LABORATORY TEST; LEUKOCYTE COUNT; LEUKOPENIA; MEDICINE; MOUTH DISEASE; MOUTH INFECTION; MYCOSIS; MYOCLONUS SEIZURE; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PATIENT CARE; PERIPHERAL EDEMA; PETECHIA; PSYCHOSIS; RASH; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SYMPTOM; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; TONIC SEIZURE; TREATMENT INDICATION; TREMOR; VOMITING; WEIGHT GAIN; WOUND HEALING IMPAIRMENT; XEROSTOMIA; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; ORAL BLEEDING; POSTOPERATIVE HEMORRHAGE;

ANTICONVULSANTS; DENTAL CARE FOR CHRONICALLY ILL; EPILEPSY; GINGIVAL HYPERTROPHY; HUMANS; ORAL HEMORRHAGE; POSTOPERATIVE HEMORRHAGE; XEROSTOMIA;

EID: 2142700847     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Fishman MC, Hoffman AR, Klausner RD, Thaler MS. Medicine, ed. 4. Philadelphia: Lippincott-Raven;1996:517-529.
2. Hauser WA, Hesdorffer DC. Epilepsy: Frequency, causes, and consequences. New York: Demos Medical Publishing;1990:1-51.
3. Leppick IE. Contemporary diagnosis and management of the patient with epilepsy, ed. 5. Newtown, PA: Handbooks in Health Care;2000:9-18.
4. Proposal for the classification of epilepsy and epileptic syndromes. Commission on Classification and Terminology of the International League against Epilepsy. Epilepsia 1989;30:389-399.
5. Annegers JF, Rocca WA, Hauser WA. Causes of epilepsy: Contributions of the Rochester epidemiology project. Mayo Clin Proc 1996;71:570-575.
6. Annegers JF, Hauser WA, Beghi E, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988;38:1407-1410.
7. Harding GF, Fylan F. Two visual mechanisms of photosensitivity. Epilepsia 1999; 40:1446-1451.
8. Aso K, Watanabe K, Negoro T, Haga Y, Kito M, Maeda N, Ohki T. Photosensitive epilepsy in children. Seizure 1994;3:67-71.
9. Duncan JS. Imaging in epilepsy. Brain 1997;120:339-377.
10. Bergen D, Bleck T, Ramsey R, Glasen R, Ristanovic R, Smith M, Whisler WW. Magnetic resonance imaging as a sensitive and specific predictor of neoplasms removed for intractable epilepsy. Epilepsia 1989;30:318-321.
11. Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a 1st unprovoked seizure: An extended follow up. Neurology 1990;40:1163-1170.
12. Shinnar S, Berg AT, Moshe SL, Petix M, Maytal J, Kang H, Goldensohn ES, Hauser WA. Risk of seizure recurrence following a first unprovoked seizure in childhood: A prospective study. Pediatrics 1990;85:1076-1085.
13. Smith D, Chadwick D. The management of epilepsy. J Neurol Neurosurg Psych 2001; 70:ii15-ii21.
14. Brodie MJ, Dichter MA. Drug therapy: Antiepileptic drugs. N Engl J Med 1996; 334:168-175.
15. Carbamazepine update. Lancet 1989;2:595-597.
16. Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia 1994;35:1026-1028.
17. Larkin JG, McKee PJW, Brodie MJ. Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients. Br J Clin Pharmacol 1992;33:111-114.
18. Selzer ME. The action of phenytoin on a composite electrical-chemical synapse in the lamprey spinal cord. Ann Neurol 1978;3:202-206.
19. Yaari Y, Pincus JH, Argov Z. Depression of synaptic transmission by diphenylhydantoin. Ann Neurol 1977;1:334-338.
20. Sodium valproate. Lancet 1988;2:1229-1231.
21. Twyman RE, Rogers CJ, Macdonald RL. Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Ann Neurol 1989;25:213-220.
22. Marson AG, Chadwick DW. New drug treatments for epilepsy. J Neurol Neurosurg Psych 2001;70:143-147.
23. Practice parameter: A guideline for discontinuing antiepileptic drugs in seizure free patients. In: Practice handbook. Minneapolis: American Academy of Neurology;1995: 187-193.
24. Little JW, Falace DA, Miller CS, Rhodus NL. Dental management of the medically compromised patient, ed. 5. St. Louis: Mosby, Inc.;1997:373-380.
25. Drug information for the health care professional, ed. 11. Rockville, MD: U.S. Pharmacopeial Convention;1991.
26. Hassell TM, White GC II, Jewson LG, Peele LC III. Valproic acid: A new antiepileptic drug with potential side effects of dental concern. J Am Dent Assoc 1979;99:983-987.
27. Loiseau P. Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 1981;22:141-146.
28. Anderson GD, Lin YX, Berge C, Ojemann GA. Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J Neurosurg 1997;87:252-256.
29. Luke DR, Rocci ML Jr., Schaible DH, Ferguson RK. Acute hepatotoxicity after excessively high doses of carbamazepine on two occasions. Pharmacotherapy 1986;6:108-111.
30. Tyler MT, Lozada-Nur F, Glick M. Clinician's guide to treatment of medically complex patients, ed. 2. Baltimore: American Academy of Oral Medicine;2001:34.
31. Lockhart PB. Oral medicine and hospital practice, ed. 4. Chicago: Federation of Special Care Organizations in Dentistry;1997: 623-626.
32. Siegel MA, Silverman S, Sollecito TP, eds. Clinician's guide to treatment of common oral conditions, ed. 5. Baltimore: American Academy of Oral Medicine;2001:10-11.
33. Silverman S. Oral cancer: Complications of therapy. Oral Surg Oral Med Oral Path Oral Radiol Endodon 1999;88:122-126.